A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Paricalcitol
Maprotiline
Aminophenazone may decrease the excretion rate of Maprotiline which could result in a higher serum level.
Paricalcitol
Azacitidine
Aminophenazone may decrease the excretion rate of Azacitidine which could result in a higher serum level.
Paricalcitol
Almotriptan
Aminophenazone may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Paricalcitol
Indobufen
The risk or severity of adverse effects can be increased when Aminophenazone is combined with Indobufen.
Paricalcitol
Nitroaspirin
The risk or severity of adverse effects can be increased when Aminophenazone is combined with Nitroaspirin.
Paricalcitol
Nimesulide
The risk or severity of adverse effects can be increased when Aminophenazone is combined with Nimesulide.
Paricalcitol
Licofelone
The risk or severity of adverse effects can be increased when Aminophenazone is combined with Licofelone.
Paricalcitol
Polmacoxib
The risk or severity of adverse effects can be increased when Aminophenazone is combined with Polmacoxib.
Paricalcitol
Flurbiprofen axetil
The risk or severity of adverse effects can be increased when Aminophenazone is combined with Flurbiprofen axetil.
Paricalcitol
Ebselen
The risk or severity of adverse effects can be increased when Aminophenazone is combined with Ebselen.
Paricalcitol
Betulinic Acid
The risk or severity of adverse effects can be increased when Aminophenazone is combined with Betulinic Acid.
Paricalcitol
Taxifolin
The risk or severity of adverse effects can be increased when Aminophenazone is combined with Taxifolin.
Paricalcitol
Dexketoprofen
The risk or severity of adverse effects can be increased when Aminophenazone is combined with Dexketoprofen.
Paricalcitol
Talniflumate
The risk or severity of adverse effects can be increased when Aminophenazone is combined with Talniflumate.
Paricalcitol
Morniflumate
The risk or severity of adverse effects can be increased when Aminophenazone is combined with Morniflumate.
Paricalcitol
Firocoxib
The risk or severity of adverse effects can be increased when Aminophenazone is combined with Firocoxib.
Paricalcitol
NS-398
The risk or severity of adverse effects can be increased when Aminophenazone is combined with NS-398.
Paricalcitol
SC-236
The risk or severity of adverse effects can be increased when Aminophenazone is combined with SC-236.
Paricalcitol
Robenacoxib
The risk or severity of adverse effects can be increased when Robenacoxib is combined with Aminophenazone.
Paricalcitol
Cimicoxib
The risk or severity of adverse effects can be increased when Cimicoxib is combined with Aminophenazone.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3